Introduction to NDC 31722-0006
The National Drug Code (NDC) 31722-0006 is assigned to a specific drug product manufactured by Camber Pharmaceuticals, Inc. To conduct a thorough market analysis and make price projections, it is crucial to understand the drug's identity, market trends, and regulatory environments.
Drug Identification
The NDC 31722-0006 corresponds to a specific drug product, but the exact name of the drug is not provided in the sources. However, based on the labeler code 31722, which is associated with Camber Pharmaceuticals, Inc., we can infer that this NDC belongs to one of the many generic drugs produced by this company. For example, Camber Pharmaceuticals produces a wide range of generic medications, including antivirals, antidepressants, and cardiovascular drugs[1].
Market Trends in Generic Drugs
Price Volatility
Generic drugs, like those produced by Camber Pharmaceuticals, are subject to significant price volatility. The Oregon Drug Price Transparency Program reported that in 2022, the median price increase for generic drugs was 19.9%, with some drugs experiencing dramatic price hikes. For instance, a generic version of naproxen saw a 2,527% price increase from 2012 to 2021[2].
Regulatory Environment
The regulatory environment plays a critical role in shaping the market for generic drugs. Programs like the Oregon Drug Price Transparency Program require manufacturers to report price increases and new high-cost drugs. This transparency is aimed at understanding and addressing the factors influencing drug prices, including interactions within the pharmaceutical supply chain, such as negotiations between manufacturers, health insurers, and pharmacy benefit managers (PBMs)[2].
Factors Influencing Drug Prices
Pharmaceutical Supply Chain
The price of a prescription drug is influenced by various entities within the pharmaceutical supply chain. This includes manufacturers, health insurers, PBMs, and hospitals. Each entity can impact the final cost to consumers through mechanisms like rebates, discounts, fees, and incentive programs. Understanding these interactions is crucial for developing policies to contain drug costs[2].
Regulatory Oversight
Regulatory bodies like the FDA and state-level programs enforce reporting requirements and monitor compliance. For example, the FDA's proposed rule to revise the National Drug Code format aims to minimize confusion and medication errors by adopting a single NDC format[4][5].
Price Projections
Historical Price Trends
Given the historical data on generic drug price increases, it is likely that the price of the drug with NDC 31722-0006 could see significant fluctuations. The median price increase of 19.9% for generic drugs in 2022 suggests that prices can rise substantially over short periods.
Regulatory Impact
The implementation of upper payment limits or other regulatory measures could cap price increases. However, as of now, such measures are still in the proposal stage and have not been widely implemented. The Oregon Drug Price Transparency Program's recommendations for legislative changes, including the consideration of an upper payment limit, indicate a potential future direction but do not currently affect the price projections[2].
Market Analysis
Competition
The generic drug market is highly competitive, with multiple manufacturers producing the same or similar drugs. This competition can drive prices down but also leads to variability in pricing strategies among different manufacturers.
Consumer Demand
Consumer demand for generic drugs is generally high due to their lower cost compared to brand-name drugs. However, changes in healthcare policies, insurance coverage, and economic conditions can influence demand and, consequently, prices.
Key Takeaways
- Price Volatility: Generic drugs are prone to significant price increases, with median increases of 19.9% reported in 2022.
- Regulatory Environment: Transparency programs and regulatory oversight are crucial in understanding and addressing price factors.
- Supply Chain Influences: Various entities within the pharmaceutical supply chain impact the final cost to consumers.
- Regulatory Proposals: Proposed changes to NDC formats and upper payment limits could influence future pricing.
FAQs
What is the NDC 31722-0006 associated with?
The NDC 31722-0006 is associated with a generic drug product manufactured by Camber Pharmaceuticals, Inc., though the exact drug name is not specified.
Why do generic drug prices fluctuate significantly?
Generic drug prices can fluctuate due to various factors, including changes in raw material costs, manufacturing processes, regulatory requirements, and market competition.
How do regulatory programs impact drug prices?
Regulatory programs, such as the Oregon Drug Price Transparency Program, aim to increase transparency and understanding of the factors influencing drug prices. They can lead to policy changes that cap price increases or set upper payment limits.
What is the role of the FDA in drug pricing?
The FDA plays a crucial role in ensuring the safety and efficacy of drugs. Proposed rules, such as the revision of the National Drug Code format, aim to minimize confusion and medication errors but do not directly control prices.
How does the pharmaceutical supply chain affect drug prices?
The pharmaceutical supply chain, including manufacturers, health insurers, PBMs, and hospitals, influences drug prices through rebates, discounts, fees, and incentive programs.
Sources
- FindACode: Camber Pharmaceuticals, Inc. - List of Drugs - NDC Labeler.
- Oregon Health Authority: Prescription Drug Price Transparency Results and Recommendations - Annual Report 2022.
- DailyMed: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE capsule, extended release.
- FDA: Future Format of the National Drug Code.
- FDA: National Drug Code Directory.
